Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Carroll

Showing results (1301-1310 of 1,434) with videos related to

Pageof 144
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 11, 2012
Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trialsRebecca J Brais, Susan E Davies, Maria O'Donovan, et al.
European Urology|April 12, 2021
Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate CancerCarissa E Chu, Mohammed Alshalalfa, Martin Sjöström, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2017
Relationships between Circulating and Intraprostatic Sex Steroid Hormone ConcentrationsMichael B Cook, Frank Z Stanczyk, Shannon N Wood, et al.
Cancer Medicine|November 21, 2022
Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancerAlice Guan, Janet K Shim, Laura Allen, et al.
The Journal of Urology|April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance StudyMeera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
Cancer|September 13, 2021
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancerPeter S Kirk, Kehao Zhu, Yingye Zheng, et al.
The Journal of Urology|May 31, 2019
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate CancerMichael D Gross, Art Sedrakyan, Fernando J Bianco, et al.
The Journal of Urology|July 13, 2022
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active SurveillanceChristopher P Filson, Kehao Zhu, Yijian Huang, et al.
European Urology|May 20, 2014
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersamplingEric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, et al.
Cancer Medicine|April 25, 2022
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillanceLauren Brady, Lisa F Newcomb, Kehao Zhu, et al.
Pageof 144

Showing results (1301-1310 of 1,434) with videos related to

Sort By:
Pageof 144
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 11, 2012
Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trialsRebecca J Brais, Susan E Davies, Maria O'Donovan, et al.
European Urology|April 12, 2021
Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate CancerCarissa E Chu, Mohammed Alshalalfa, Martin Sjöström, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2017
Relationships between Circulating and Intraprostatic Sex Steroid Hormone ConcentrationsMichael B Cook, Frank Z Stanczyk, Shannon N Wood, et al.
Cancer Medicine|November 21, 2022
Factors that influence treatment decisions: A qualitative study of racially and ethnically diverse patients with low- and very-low risk prostate cancerAlice Guan, Janet K Shim, Laura Allen, et al.
The Journal of Urology|April 30, 2025
Magnetic Resonance Imaging at Second Surveillance Biopsy After Diagnosis in Patients With Grade Group 1 Prostate Cancer in the Canary Prostate Active Surveillance StudyMeera R Chappidi, Lisa F Newcomb, Yingye Zheng, et al.
Cancer|September 13, 2021
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancerPeter S Kirk, Kehao Zhu, Yingye Zheng, et al.
The Journal of Urology|May 31, 2019
SPARED Collaboration: Patient Selection for Partial Gland Ablation in Men with Localized Prostate CancerMichael D Gross, Art Sedrakyan, Fernando J Bianco, et al.
The Journal of Urology|July 13, 2022
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active SurveillanceChristopher P Filson, Kehao Zhu, Yijian Huang, et al.
European Urology|May 20, 2014
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersamplingEric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, et al.
Cancer Medicine|April 25, 2022
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillanceLauren Brady, Lisa F Newcomb, Kehao Zhu, et al.
Pageof 144